Literature DB >> 9721757

Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro.

M Kubes1, J Cordier, J Glowinski, J A Girault, H Chneiweiss.   

Abstract

PEA-15 (phosphoprotein enriched in astrocytes, Mr = 15,000) is an acidic serine-phosphorylated protein highly expressed in the CNS, where it can play a protective role against cytokine-induced apoptosis. PEA-15 is a major substrate for protein kinase C. Endothelins, which are known to exert pleiotropic effects on astrocytes, were used to analyze further the processes involved in PEA-15 phosphorylation. Endothelin-1 or endothelin-3 (0.1 microM) induced a robust phosphorylation of PEA-15 that was abolished by the removal of extracellular calcium, but only diminished by inhibitors of protein kinase C. Microsequencing of phosphopeptides generated by digestion of PEA-15 following endothelin-1 treatment identified two phosphorylated residues: Ser104, previously recognized as the protein kinase C site, and a novel phosphoserine, Ser116, located in a consensus motif for either protein kinase casein kinase II or calcium/calmodulin-dependent protein kinase II (CaMKII). Partly purified PEA-15 was a substrate in vitro for CaMKII, but not for casein kinase II. Two-dimensional phosphopeptide mapping demonstrated that the site phosphorylated in vitro by CaMKII was also phosphorylated in intact astrocytes in response to endothelin. CaMKII phosphorylated selectively Ser116 and had no effect on Ser104, but in vitro phosphorylation by CaMKII appeared to facilitate further phosphorylation by protein kinase C. Treatment of intact astrocytes with okadaic acid enhanced the phosphorylation of the CaMKII site. These results demonstrate that PEA-15 is phosphorylated in astrocytes by CaMKII (or a related kinase) and by protein kinase C in response to endothelin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721757     DOI: 10.1046/j.1471-4159.1998.71031307.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  27 in total

1.  The PEA-15 protein regulates autophagy via activation of JNK.

Authors:  Barbara C Böck; Katrin E Tagscherer; Anne Fassl; Anika Krämer; Ina Oehme; Hans-Walter Zentgraf; Martina Keith; Wilfried Roth
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis.

Authors:  Yosuke Watanabe; Fumiyuki Yamasaki; Yoshinori Kajiwara; Taiichi Saito; Takeshi Nishimoto; Chandra Bartholomeusz; Naoto T Ueno; Kazuhiko Sugiyama; Kaoru Kurisu
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

3.  Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action.

Authors:  Alessandra Trencia; Anna Perfetti; Angela Cassese; Giovanni Vigliotta; Claudia Miele; Francesco Oriente; Stefania Santopietro; Ferdinando Giacco; Gerolama Condorelli; Pietro Formisano; Francesco Beguinot
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

4.  A phospholipase Cγ1-activated pathway regulates transcription in human vascular smooth muscle cells.

Authors:  Irene Hunter; Keith S Mascall; Joe W Ramos; Graeme F Nixon
Journal:  Cardiovasc Res       Date:  2011-02-01       Impact factor: 10.787

5.  ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.

Authors:  Hema Vaidyanathan; John Opoku-Ansah; Sandra Pastorino; Hema Renganathan; Michelle L Matter; Joe W Ramos
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

6.  Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.

Authors:  Peiyong Zhai; Mitsutaka Yamamoto; Jonathan Galeotti; Jing Liu; Malthi Masurekar; Jill Thaisz; Keiichi Irie; Eric Holle; Xianzhong Yu; Sabina Kupershmidt; Dan M Roden; Thomas Wagner; Atsuko Yatani; Dorothy E Vatner; Stephen F Vatner; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

7.  Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis.

Authors:  D Kitsberg; E Formstecher; M Fauquet; M Kubes; J Cordier; B Canton; G Pan; M Rolli; J Glowinski; H Chneiweiss
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

8.  Bisphosphorylated PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIP.

Authors:  Xuemei Xie; Chandra Bartholomeusz; Ahmed A Ahmed; Anna Kazansky; Lixia Diao; Keith A Baggerly; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  Mol Cancer Ther       Date:  2013-03-29       Impact factor: 6.261

9.  Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism.

Authors:  François Renault-Mihara; Frédéric Beuvon; Xavier Iturrioz; Brigitte Canton; Sophie De Bouard; Nadine Léonard; Shahul Mouhamad; Ariane Sharif; Joe W Ramos; Marie-Pierre Junier; Hervé Chneiweiss
Journal:  Mol Biol Cell       Date:  2006-09-20       Impact factor: 4.138

10.  PTEN loss promotes mitochondrially dependent type II Fas-induced apoptosis via PEA-15.

Authors:  James W Peacock; Jodie Palmer; Dieter Fink; Stephen Ip; Eric M Pietras; Alice L-F Mui; Stephen W Chung; Martin E Gleave; Michael E Cox; Ramon Parsons; Marcus E Peter; Christopher J Ong
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.